Medtronic plc (MDT) Balance Sheet
MDT balance sheet, FY2026
April 30, 2026 · U.S. dollars$93.03B assets = $42.96B liabilities + $50.07B equity
Both columns are drawn to the same scale: what MDT owns equals what it owes plus shareholders’ equity. Hover a block for its value.
MDT financial health
Current ratio2.13
Comfortable · current assets cover current liabilities 2.13×
Debt / equity0.57
Moderate leverage · $0.57 of debt for each $1 of equity
Equity / assets53.2%
Equity-funded · of assets funded by shareholders
Cash / debt33.0%
Low cash cover · cash & short-term investments vs total debt
Goodwill & intangibles56.7%
Mostly intangible · of total assets
Descriptive bands, not a rating. Fiscal FY2026.
MDT balance sheet trends, FY2017–FY2026
| Metric | Trend | Then | Latest | Change |
|---|---|---|---|---|
| Total assets | $99.82BFY2017 | $93.03BFY2026 | −0.8%/yr | |
| Total liabilities | $49.40BFY2017 | $42.96BFY2026 | −1.5%/yr | |
| Shareholders’ equity | $50.29BFY2017 | $49.46BFY2026 | −0.2%/yr | |
| Cash & short-term investments | $13.71BFY2017 | $9.22BFY2026 | −4.3%/yr | |
| Total debt | $33.40BFY2017 | $27.96BFY2026 | −2.0%/yr | |
| Net cash (debt) | −$19.69BFY2017 | −$18.74BFY2026 | +$952.0M | |
| Working capital | $10.61BFY2017 | $13.13BFY2026 | +$2.5B | |
| Book value per share | $36.15FY2017 | $38.40FY2026 | +0.7%/yr | |
| Current ratio | 1.74FY2017 | 2.13FY2026 | +0.38 | |
| Debt / equity | 0.66FY2017 | 0.57FY2026 | −0.10 | |
| Shares outstanding | 1.39BFY2017 | 1.29BFY2026 | −0.9%/yr |
Change is the average annual growth (CAGR) or the difference between the first and latest year.
MDT assets
Cash & ST investmentsReceivablesInventoryOther currentPP&EGoodwill & intangiblesLT investmentsOther non-current
MDT liabilities and equity
Current liabilitiesLong-term debtOther long-term liabilitiesEquity
MDT debt vs cash
Total debtCash & ST investmentsNet cash (debt)
Debt includes short- and long-term borrowings and, where reported, lease obligations.
MDT balance sheet
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Cash & short-term investments | $9.22B | $8.96B | $8.01B | $7.96B | $10.57B | $10.82B | $10.95B | $9.85B | $11.23B | $13.71B |
| Cash & equivalents | $1.95B | $2.22B | $1.28B | $1.54B | $3.71B | $3.59B | $4.14B | $4.39B | $3.67B | $4.97B |
| Short-term investments | $7.27B | $6.75B | $6.72B | $6.42B | $6.86B | $7.22B | $6.81B | $5.46B | $7.56B | $8.74B |
| Receivables | $6.64B | $6.51B | $6.13B | $6.00B | $5.55B | $5.46B | $4.64B | $6.22B | $5.99B | $5.59B |
| Inventory | $5.95B | $5.48B | $5.22B | $5.29B | $4.62B | $4.31B | $4.23B | $3.75B | $3.58B | $3.34B |
| Other current assets | $2.97B | $2.86B | $2.58B | $2.42B | $2.32B | $1.96B | $2.21B | $2.14B | $2.19B | $2.24B |
| Total current assets | $24.79B | $23.81B | $21.93B | $21.68B | $23.06B | $22.55B | $22.03B | $21.97B | $22.98B | $24.87B |
| Property, plant & equipment (net) | $7.42B | $6.84B | $6.13B | $5.57B | $5.41B | $5.22B | $4.83B | $4.67B | $4.60B | $4.36B |
| Goodwill & intangible assets | $52.73B | $53.40B | $54.21B | $56.27B | $56.10B | $59.70B | $58.90B | $60.52B | $61.27B | $61.92B |
| Long-term investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $416.0M | $559.0M | $736.0M |
| Other non-current assets | $8.09B | $7.62B | $7.70B | $7.43B | $6.41B | $5.61B | $4.93B | $2.12B | $1.98B | $7.92B |
| Total assets | $93.03B | $91.68B | $89.98B | $90.95B | $90.98B | $93.08B | $90.69B | $89.69B | $91.39B | $99.82B |
| Liabilities | ||||||||||
| Accounts payable | $2.64B | $2.45B | $2.41B | $2.66B | $2.28B | $2.11B | $2.00B | $1.95B | $1.63B | $1.55B |
| Short-term debt | $1.79B | $2.87B | $1.09B | $20.0M | $3.74B | $11.0M | $2.78B | $838.0M | $2.06B | $7.53B |
| Deferred revenue | — | — | −$1.33B | $314.0M | $305.0M | $276.0M | — | $315.0M | — | $4.93B |
| Total current liabilities | $11.66B | $12.88B | $10.79B | $9.05B | $12.39B | $8.51B | $10.37B | $8.47B | $10.08B | $14.26B |
| Long-term debt | $26.12B | $25.64B | $23.93B | $24.34B | $20.37B | $26.38B | $22.02B | $24.49B | $23.70B | $25.92B |
| Lease obligations | $60.0M | $58.0M | $61.0M | $64.0M | $62.0M | $71.0M | $50.0M | $16.0M | $26.0M | $28.0M |
| Other long-term liabilities | $5.18B | $4.90B | $4.84B | $5.89B | $5.49B | $6.59B | $7.43B | $6.52B | $6.79B | $9.26B |
| Total liabilities | $42.96B | $43.42B | $39.56B | $39.28B | $38.26B | $41.48B | $39.82B | $39.48B | $40.57B | $49.40B |
| Shareholders' equity | ||||||||||
| Common stock & paid-in capital | — | $128,190 | $131,130 | $133,100 | $133,070 | $134,540 | $134,110 | $134,070 | $34.12B | $32.20B |
| Retained earnings (deficit) | $32.64B | $31.48B | $30.40B | $30.39B | $30.25B | $28.59B | $28.13B | $26.27B | $24.38B | $23.36B |
| Treasury stock | — | — | — | — | — | — | — | $0 | $0 | $0 |
| Accumulated other comprehensive income | −$4.10B | −$4.28B | −$3.32B | −$3.50B | −$2.27B | −$3.48B | −$3.56B | −$2.71B | −$1.79B | −$2.61B |
| Minority interest | $609.0M | $232.0M | $206.0M | $182.0M | $171.0M | $174.0M | $135.0M | $121.0M | $102.0M | $122.0M |
| Total shareholders' equity | $49.46B | $48.02B | $50.21B | $51.48B | $52.55B | $51.43B | $50.74B | $50.09B | $50.72B | $50.29B |
| Key figures | ||||||||||
| Total debt | $27.96B | $28.52B | $25.02B | $24.36B | $24.11B | $26.39B | $24.80B | $25.32B | $25.76B | $33.40B |
| Net cash (debt) | −$18.74B | −$19.55B | −$17.02B | −$16.41B | −$13.54B | −$15.57B | −$13.85B | −$15.47B | −$14.54B | −$19.69B |
| Working capital | $13.13B | $10.94B | $11.15B | $12.62B | $10.66B | $14.04B | $11.66B | $13.49B | $12.90B | $10.61B |
| Tangible book value | −$3.27B | −$5.38B | −$4.00B | −$4.79B | −$3.54B | −$8.27B | −$8.17B | −$10.43B | −$10.55B | −$11.63B |
| Book value per share | $38.40 | $37.23 | $37.75 | $38.63 | $38.89 | $37.98 | $37.55 | $36.90 | $37.07 | $36.15 |
| Shares outstanding | 1.29B | 1.29B | 1.33B | 1.33B | 1.35B | 1.35B | 1.35B | 1.36B | 1.37B | 1.39B |
| Current ratio | 2.13 | 1.85 | 2.03 | 2.39 | 1.86 | 2.65 | 2.13 | 2.59 | 2.28 | 1.74 |
| Quick ratio | 1.36 | 1.20 | 1.31 | 1.54 | 1.30 | 1.91 | 1.50 | 1.90 | 1.71 | 1.35 |
| Debt / equity | 0.57 | 0.59 | 0.50 | 0.47 | 0.46 | 0.51 | 0.49 | 0.51 | 0.51 | 0.66 |
| Equity / assets | 53.2% | 52.4% | 55.8% | 56.6% | 57.8% | 55.2% | 55.9% | 55.8% | 55.5% | 50.4% |
| Jul '26 | Apr '26 | Jan '26 | Oct '25 | Jul '25 | Apr '25 | Jan '25 | Oct '24 | Jul '24 | Apr '24 | Jan '24 | Oct '23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||
| Cash & short-term investments | $8.82B | $9.22B | $8.38B | $8.33B | $8.12B | $8.96B | $7.92B | $7.99B | $7.84B | $8.01B | $8.32B | $7.73B |
| Cash & equivalents | $1.69B | $1.95B | $1.15B | $1.28B | $1.27B | $2.22B | $1.24B | $1.39B | $1.31B | $1.28B | $1.62B | $1.31B |
| Short-term investments | $7.13B | $7.27B | $7.24B | $7.04B | $6.85B | $6.75B | $6.68B | $6.59B | $6.53B | $6.72B | $6.70B | $6.42B |
| Receivables | $224.0M | $6.64B | $87.0M | $6.39B | $6.26B | $6.51B | $6.12B | $6.26B | $6.01B | $6.13B | $5.97B | $5.93B |
| Inventory | −$240.0M | $5.95B | −$803.0M | $6.16B | −$373.0M | $5.48B | $5.61B | $5.48B | $5.41B | $5.22B | $5.73B | $5.75B |
| Other current assets | $15.59B | $2.97B | $16.40B | $3.12B | $9.21B | $2.86B | $2.87B | $2.71B | $2.68B | $2.58B | $2.50B | $2.66B |
| Total current assets | $24.39B | $24.79B | $24.07B | $24.00B | $23.22B | $23.81B | $22.51B | $22.44B | $21.95B | $21.93B | $22.51B | $22.08B |
| Property, plant & equipment (net) | −$503.0M | $7.42B | −$1.42B | $7.16B | −$504.0M | $6.84B | $6.59B | $6.44B | $6.28B | $6.13B | $5.84B | $5.74B |
| Goodwill & intangible assets | $53.42B | $52.73B | $52.23B | $52.58B | $53.23B | $53.40B | $53.00B | $53.59B | $53.90B | $54.21B | $54.85B | $54.88B |
| Long-term investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other non-current assets | $15.99B | $8.09B | $16.60B | $7.61B | $15.02B | $7.62B | $7.86B | $7.58B | $7.62B | $7.70B | $7.63B | $7.39B |
| Total assets | $93.31B | $93.03B | $91.48B | $91.35B | $90.97B | $91.68B | $89.97B | $90.04B | $89.75B | $89.98B | $90.84B | $90.09B |
| Liabilities | ||||||||||||
| Accounts payable | $2.69B | $2.64B | $2.57B | $2.58B | $2.56B | $2.45B | $2.29B | $2.38B | $2.29B | $2.41B | $1.99B | $2.17B |
| Short-term debt | $2.54B | $1.79B | $191.0M | $1.42B | $2.43B | $2.87B | $2.62B | $3.72B | $1.55B | $1.09B | $1.03B | $1.34B |
| Deferred revenue | — | — | — | — | — | — | — | — | $362.0M | $352.0M | $350.0M | $6.14B |
| Total current liabilities | $11.80B | $11.66B | $9.49B | $9.94B | $11.53B | $12.88B | $11.84B | $12.20B | $10.29B | $10.79B | $9.79B | $9.66B |
| Long-term debt | $25.57B | $26.12B | $27.88B | $27.68B | $26.18B | $25.64B | $23.98B | $24.61B | $26.26B | $23.88B | $24.10B | $23.74B |
| Lease obligations | $52.0M | $60.0M | $58.0M | $55.0M | $51.0M | $58.0M | $50.0M | $50.0M | $52.0M | $61.0M | $56.0M | $56.0M |
| Other long-term liabilities | $5.09B | $5.18B | $4.91B | $4.87B | $5.13B | $4.90B | $4.53B | $4.52B | $5.04B | $4.89B | $4.95B | $5.04B |
| Total liabilities | $42.46B | $42.96B | $42.29B | $42.49B | $42.84B | $43.42B | $40.36B | $41.33B | $41.59B | $39.56B | $38.84B | $38.44B |
| Shareholders' equity | ||||||||||||
| Common stock & paid-in capital | −$247.0M | — | −$181.0M | $128,100 | −$28.0M | $128,190 | $0 | $128,250 | — | — | — | — |
| Retained earnings (deficit) | $33.19B | $32.64B | $32.30B | $32.07B | $31.61B | $31.48B | $31.32B | $30.92B | $30.55B | $30.40B | $30.66B | $30.26B |
| Accumulated other comprehensive income | −$3.76B | −$4.10B | −$4.33B | −$4.28B | −$4.60B | −$4.28B | −$2.84B | −$3.25B | −$3.41B | −$3.32B | −$3.46B | −$3.38B |
| Minority interest | $618.0M | $609.0M | $211.0M | $204.0M | $240.0M | — | — | — | — | — | — | — |
| Total shareholders' equity | $50.23B | $49.46B | $48.98B | $48.65B | $47.89B | $48.02B | $49.39B | $48.49B | $47.95B | $50.21B | $51.79B | $51.46B |
| Key figures | ||||||||||||
| Total debt | $28.15B | $27.96B | $28.07B | $29.10B | $28.61B | $28.52B | $26.61B | $28.33B | $27.86B | $25.02B | $25.18B | $25.08B |
| Net cash (debt) | −$19.33B | −$18.74B | −$19.69B | −$20.77B | −$20.49B | −$19.55B | −$18.68B | −$20.34B | −$20.02B | −$17.02B | −$16.86B | −$17.35B |
| Working capital | $12.59B | $13.13B | $14.58B | $14.06B | $11.69B | $10.94B | $10.67B | $10.24B | $11.66B | $11.15B | $12.72B | $12.42B |
| Tangible book value | −$3.19B | −$3.27B | −$3.24B | −$3.93B | −$5.34B | −$5.38B | −$3.62B | −$5.09B | −$5.95B | −$4.00B | −$3.06B | −$3.42B |
| Book value per share | $39.09 | $38.40 | $38.03 | $37.79 | $37.21 | $37.29 | $38.40 | $37.68 | $36.98 | $37.89 | $38.89 | $38.64 |
| Shares outstanding | 1.29B | 1.29B | 1.29B | 1.29B | 1.29B | 1.29B | 1.29B | 1.29B | 1.30B | 1.33B | 1.33B | 1.33B |
| Current ratio | 2.07 | 2.13 | 2.54 | 2.42 | 2.01 | 1.85 | 1.90 | 1.84 | 2.13 | 2.03 | 2.30 | 2.29 |
| Quick ratio | 0.77 | 1.36 | 0.89 | 1.48 | 1.25 | 1.20 | 1.19 | 1.17 | 1.35 | 1.31 | 1.46 | 1.42 |
| Debt / equity | 0.56 | 0.57 | 0.57 | 0.60 | 0.60 | 0.59 | 0.54 | 0.58 | 0.58 | 0.50 | 0.49 | 0.49 |
| Equity / assets | 53.8% | 53.2% | 53.5% | 53.3% | 52.6% | 52.4% | 54.9% | 53.9% | 53.4% | 55.8% | 57.0% | 57.1% |
Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported (latest annual report filed June 18, 2026); data from EODHD.
MDT financial position
At the end of fiscal 2026 (April 30, 2026), Medtronic had total assets of $93.0 billion (up 1.5% from a year earlier), total liabilities of $43.0 billion and shareholders' equity of $49.5 billion. It held $9.2 billion in cash and short-term investments against $28.0 billion of debt, net debt of $18.7 billion. Its current ratio was 2.13. In the latest quarter (ended July 31, 2026) total assets were $93.3 billion and equity $50.2 billion.
Related: MDT income statement, MDT cash flow statement, MDT key metrics. See the MDT stock overview for the latest quote and news.
MDT balance sheet FAQ
What are Medtronic's total assets?
Medtronic reported total assets of $93.0 billion at the end of fiscal 2026 (April 30, 2026), compared with $91.7 billion a year earlier.
How much debt does Medtronic have?
Medtronic had $28.0 billion of total debt at the end of fiscal 2026, including short-term borrowings and lease obligations. Its debt-to-equity ratio was 0.57.
How much cash does Medtronic have?
Medtronic held $9.2 billion in cash and short-term investments at the end of fiscal 2026; with $28.0 billion of debt that is net debt of $18.7 billion.
What is Medtronic's book value?
Medtronic's shareholders' equity (book value) was $49.5 billion at the end of fiscal 2026, or $38.40 per share.
What is Medtronic's current ratio?
Medtronic had current assets of $24.8 billion and current liabilities of $11.7 billion, a current ratio of 2.13 (it can cover its short-term obligations).
How much goodwill does Medtronic have?
Medtronic carried $52.7 billion of goodwill and intangible assets, 56.7% of total assets, at the end of fiscal 2026.